BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2442933)

  • 1. Histological and immunological features of primary Kaposi's sarcoma: evaluation before and after chemotherapy.
    Brambilla L; Boneschi V; Pigatto PD; Finzi AF; Marinig C; Renoldi P; Fiorini GF
    Acta Derm Venereol; 1987; 67(3):211-7. PubMed ID: 2442933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classic and iatrogenic Kaposi's sarcoma. Histopathological patterns as related to clinical course.
    Friedman-Birnbaum R; Bergman R; Bitterman-Deutsch O; Weltfriend S; Lichtig C
    Am J Dermatopathol; 1993 Dec; 15(6):523-7. PubMed ID: 8311180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistological evaluation of immune cell infiltrate in cutaneous Kaposi's sarcoma.
    Hussein MR
    Cell Biol Int; 2008 Jan; 32(1):157-62. PubMed ID: 17950633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spindle-shaped cells in cutaneous Kaposi's sarcoma. Histologic simulators include factor XIIIa dermal dendrocytes.
    Nickoloff BJ; Griffiths CE
    Am J Pathol; 1989 Nov; 135(5):793-800. PubMed ID: 2573283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of spindle cells in Kaposi's sarcoma: comparison of cells in lesions and in culture.
    Kaaya EE; Parravicini C; Ordonez C; Gendelman R; Berti E; Gallo RC; Biberfeld P
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):295-305. PubMed ID: 7552491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
    Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
    Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunological aspects of Kaposi's disease].
    Shaposhnikov OK; Karachunova TN
    Vopr Onkol; 1985; 31(12):18-23. PubMed ID: 3002041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaposi's sarcoma in a young man in absence of AIDS or other known causes of immune suppression.
    Calzavara-Pinton P; Cattaneo R; Franceschini F; Airò P
    Boll Ist Sieroter Milan; 1987; 66(3):239-42. PubMed ID: 3435654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinico-immunological characteristics of Kaposi's disease].
    Shaposhnikov OK; Karachunova TN
    Vestn Dermatol Venerol; 1985 Jun; (6):4-6. PubMed ID: 3875948
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravascular Kaposi's sarcoma - a hitherto unrecognized phenomenon.
    Luzar B; Antony F; Ramdial PK; Calonje E
    J Cutan Pathol; 2007 Nov; 34(11):861-4. PubMed ID: 17944727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kaposi's sarcoma].
    Hayasaka K; Ishihara K
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1749-54. PubMed ID: 3839998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunologic and immunogenetic studies in Kaposi's sarcoma].
    Kadagidze ZG; Kalamkarian AA; Kerimov SG; Derevnina NA; Mazina NM
    Vestn Dermatol Venerol; 1987; (11):15-20. PubMed ID: 3501921
    [No Abstract]   [Full Text] [Related]  

  • 14. Classic and immunodeficiency-associated Kaposi's sarcoma. Clinical, histologic, and immunologic correlations.
    Santucci M; Pimpinelli N; Moretti S; Giannotti B
    Arch Pathol Lab Med; 1988 Dec; 112(12):1214-20. PubMed ID: 3056319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenetic role of HIV infection in Kaposi's sarcoma of equatorial East Africa.
    Craighead J; Moore A; Grossman H; Ershler W; Frattini U; Saxinger C; Hess U; Ngowi F
    Arch Pathol Lab Med; 1988 Mar; 112(3):259-65. PubMed ID: 3257865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
    Bower M; Weir J; Francis N; Newsom-Davis T; Powles S; Crook T; Boffito M; Gazzard B; Nelson M
    AIDS; 2009 Aug; 23(13):1701-6. PubMed ID: 19550283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary evaluation of in vivo reflectance confocal microscopy features of Kaposi's sarcoma.
    Grazziotin TC; Cota C; Buffon RB; Araújo Pinto L; Latini A; Ardigò M
    Dermatology; 2010; 220(4):346-54. PubMed ID: 20453469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AIDS-related Kaposi's sarcoma patients with visceral manifestations. Response to human chorionic gonadotropin preparations.
    Hermans P; Clumeck N; Picard O; van Vooren JP; Duriez P; Zucman D; Bryant JL; Gill P; Lunardi-Iskandar Y; Gallo RC
    J Hum Virol; 1998; 1(2):82-9. PubMed ID: 10195236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment.
    Dezube BJ
    Expert Rev Anticancer Ther; 2002 Apr; 2(2):193-200. PubMed ID: 12113241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous and lymphadenopathic Kaposi's sarcoma: a case report and review of literature.
    Hussein MR
    J Cutan Pathol; 2008 Jun; 35(6):575-8. PubMed ID: 18261114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.